在患有B系急性淋巴细胞白血病的儿科患者中,CD20抗原表达的相关性
Karthik Bommannan1, Jhansi Rani Arumugam1, Venkatraman Radhakrishnan2
1Department of Oncopathology, Cancer Institute (W.I.A.), Chennai, India.
British journal of haematology
|March 6, 2024
概括
儿科B系急性淋巴细胞白血病 (B-ALL) 中的CD20表达与更高的复发率有关. 即使在CD20阴性B-ALL中,残留疾病也显示CD20的表达增加,这表明有针对性的治疗的潜力.
科学领域:
- 儿科瘤学 儿科瘤学
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 在儿科B系急性淋巴细胞白血病 (B-ALL) 中CD20抗原表达的预后相关性尚未得到充分确立.
- CD20表达在50%的未经治疗的儿科B-ALL患者中被发现.
研究的目的:
- 调查CD20表达在儿科B-ALL中的预后意义.
- 分析与CD20表达相关的临床,实验室和生存数据.
主要方法:
- 对224名未经治疗的儿科B-ALL患者的临床和实验室参数的分析.
- 评估生存特征,包括复发率和无复发生存率,基于CD20表达.
- 评估诱导可测残留疾病 (EOI-MRD) 的末期和CD20表达强度的残留爆发.
主要成果:
- 与CD20阳性 (CD20+) B-ALL患者相比,CD20阴性 (CD20-) 患者的复发率增加了两倍 (29%对16%) 和无复发生存率低 (66%对79%).
- CD20表达被确定为较低无复发存活率的独立预测因素.
- CD20-B-ALL患者的残留爆发显示CD20表达强度和数量的显著增加,接近CD20+B-ALL患者的水平.
结论:
- CD20表达是小儿B-ALL复发的重要独立预测因子.
- CD20阴性B-ALL患者的残留白血病细胞可以调高CD20的表达,这表明CD20向治疗的潜在作用,如Rituximab.
- 考虑Rituximab在管理EOI-MRD阳性CD20-B-ALL患者时是有必要的,因为CD20表达在残留芽细胞上增加了.
关键词:
B 血统 B 血统 B 血统 B 血统CD20 CD20 是一个CD20 CD20 是一个CD20.急性淋巴细胞白血病急性淋巴细胞白血病可测量的残留疾病.儿科 儿科 儿科这就是Rituximab.更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
12:16A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
14.7K
相关概念视频
01:21Lineage Commitment
Commitment is the process whereby stem cells:
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...